JP2005508940A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508940A5 JP2005508940A5 JP2003533918A JP2003533918A JP2005508940A5 JP 2005508940 A5 JP2005508940 A5 JP 2005508940A5 JP 2003533918 A JP2003533918 A JP 2003533918A JP 2003533918 A JP2003533918 A JP 2003533918A JP 2005508940 A5 JP2005508940 A5 JP 2005508940A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- alkyl
- hydroxy
- unsubstituted
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *C(C[C@@](*)C(BI)=*)CN(*)C(*)C(I)=* Chemical compound *C(C[C@@](*)C(BI)=*)CN(*)C(*)C(I)=* 0.000 description 6
- XDOIVOKWAWFBRI-UHFFFAOYSA-N CC[ClH]C(OC)=O Chemical compound CC[ClH]C(OC)=O XDOIVOKWAWFBRI-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32724301P | 2001-10-05 | 2001-10-05 | |
| PCT/US2002/032010 WO2003030886A2 (en) | 2001-10-05 | 2002-10-04 | Allylamides useful in the treatment of alzheimer's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005508940A JP2005508940A (ja) | 2005-04-07 |
| JP2005508940A5 true JP2005508940A5 (https=) | 2006-01-05 |
Family
ID=23275725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003533918A Pending JP2005508940A (ja) | 2001-10-05 | 2002-10-04 | アルツハイマー病の治療に有用なアリルアミド |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20050027007A1 (https=) |
| EP (1) | EP1434580A2 (https=) |
| JP (1) | JP2005508940A (https=) |
| AU (1) | AU2002335794A1 (https=) |
| BR (1) | BR0213138A (https=) |
| CA (1) | CA2462875A1 (https=) |
| MX (1) | MXPA04003244A (https=) |
| WO (1) | WO2003030886A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7521481B2 (en) | 2003-02-27 | 2009-04-21 | Mclaurin Joanne | Methods of preventing, treating and diagnosing disorders of protein aggregation |
| CN100475786C (zh) * | 2005-02-18 | 2009-04-08 | 中国科学院上海药物研究所 | 一类4-羟基戊酰胺类化合物及其制备方法和用途 |
| US7838676B2 (en) | 2005-11-21 | 2010-11-23 | Amgen Inc. | Beta-secretase modulators and methods of use |
| US7872009B2 (en) | 2005-11-21 | 2011-01-18 | Amgen Inc. | Beta-Secretase modulators and methods of use |
| US7745484B2 (en) | 2005-11-21 | 2010-06-29 | Amgen Inc. | Beta-secretase modulators and methods of use |
| WO2007061670A1 (en) | 2005-11-21 | 2007-05-31 | Amgen Inc. | Beta-secretase modulators and methods of use |
| CA2676715A1 (en) | 2007-02-12 | 2008-08-21 | Merck & Co., Inc. | Piperazine derivatives for treatment of ad and related conditions |
| CA2687608C (en) | 2007-05-25 | 2013-07-02 | Amgen Inc. | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| US8163909B2 (en) | 2007-05-25 | 2012-04-24 | Amgen Inc. | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| US7803809B2 (en) | 2008-11-12 | 2010-09-28 | Amgen Inc. | Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use |
| WO2009128057A2 (en) | 2008-04-18 | 2009-10-22 | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al | Psycho-pharmaceuticals |
| CA2736130C (en) | 2008-09-11 | 2014-01-14 | Amgen Inc. | Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use |
| US9296698B2 (en) | 2009-11-23 | 2016-03-29 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| EP2504330A1 (en) | 2009-11-23 | 2012-10-03 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| AU2011207679B2 (en) | 2010-01-19 | 2013-10-10 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| MX2012010657A (es) | 2010-03-15 | 2013-02-07 | Amgen Inc | Compuestos de espiro amino-dihidrooxazina y amino-dihidrotiazina como moduladores de beta-secretasa y su uso medico. |
| EP2547685A1 (en) | 2010-03-15 | 2013-01-23 | Amgen Inc. | Spiro-tetracyclic ring compounds as beta - secretase modulators |
| EP2673279A1 (en) | 2011-02-07 | 2013-12-18 | Amgen Inc. | 5-amino-oxazepine and 5-amino-thiazepane compounds as beta-secretase antagonists and methods of use |
| WO2013044092A1 (en) | 2011-09-21 | 2013-03-28 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| WO2014078314A1 (en) | 2012-11-15 | 2014-05-22 | Amgen Inc. | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| CN111087386B (zh) * | 2020-01-02 | 2020-12-18 | 牡丹江医学院 | 一种用于治疗阿尔茨海默病的化合物及其合成方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE163926T1 (de) * | 1991-11-08 | 1998-03-15 | Merck & Co Inc | Hiv-protease-inhibitoren verwendbar in der aids- behandlung |
| AU8017298A (en) * | 1997-05-17 | 1998-12-11 | Glaxo Group Limited | Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
| US20020147197A1 (en) * | 1999-10-08 | 2002-10-10 | Newman Michael J. | Methods and compositions for enhancing pharmaceutical treatments |
| DE60124080T2 (de) * | 2000-03-23 | 2007-03-01 | Elan Pharmaceuticals, Inc., San Francisco | Verbindungen und verfahren zur behandlung der alzheimerschen krankheit |
| AU2001259817A1 (en) * | 2000-05-04 | 2001-11-12 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The National Institutes Of Health | Methods of and compounds for inhibiting calpains |
-
2002
- 2002-10-04 US US10/491,841 patent/US20050027007A1/en not_active Abandoned
- 2002-10-04 JP JP2003533918A patent/JP2005508940A/ja active Pending
- 2002-10-04 EP EP02770558A patent/EP1434580A2/en not_active Withdrawn
- 2002-10-04 CA CA002462875A patent/CA2462875A1/en not_active Abandoned
- 2002-10-04 MX MXPA04003244A patent/MXPA04003244A/es not_active Application Discontinuation
- 2002-10-04 AU AU2002335794A patent/AU2002335794A1/en not_active Abandoned
- 2002-10-04 WO PCT/US2002/032010 patent/WO2003030886A2/en not_active Ceased
- 2002-10-04 BR BR0213138-2A patent/BR0213138A/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508940A5 (https=) | ||
| AU2006332677B2 (en) | Methods for treating cutaneous lupus using aminoisoindoline compounds | |
| JP2011503045A (ja) | Ｃｒｔｈ２拮抗化合物の使用 | |
| JP2005516967A (ja) | β−セクレターゼインヒビター | |
| WO2009063215A2 (en) | Use of crth2 antagonist compounds | |
| US20110124683A1 (en) | Use of CRTH2 Antagonist Compounds | |
| JP2001510154A (ja) | カッパアゴニスト化合物、製剤、ならびにそれらによる掻痒の予防法および治療法 | |
| JP5674676B2 (ja) | 結腸癌発生を予防または低減する方法 | |
| US6946474B2 (en) | Nitrogen-containing compounds and their use as glycine transport inhibitors | |
| JP2004536071A (ja) | 複素環ベータアミノ酸およびそれらの抗癲癇誘発剤としての使用 | |
| JP2005508940A (ja) | アルツハイマー病の治療に有用なアリルアミド | |
| JP6498195B2 (ja) | 代謝疾患を処置するためのｐｐａｒ節約化合物 | |
| MX2008015860A (es) | Combinaciones que comprenden moduladores de 5ht6 e inhibidores de la colinesterasa. | |
| JP2005535559A (ja) | アルツハイマー病を治療するためのヒドロキシ置換アミド | |
| JP2005514370A5 (https=) | ||
| JP2002501039A5 (https=) | ||
| WO2019193161A1 (en) | Bumetanide derivatives for the therapy of stroke and other neurological diseases/disorders involving nkccs | |
| MXPA04004903A (es) | Derivados de aminoacido utiles para el tratamiento de la enfermedad de alzheimer. | |
| CA2680324A1 (en) | Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds | |
| RU2003101396A (ru) | Замещенные нитрированные катехолы, их применение в лечении некоторых расстройств центральной и периферической нервной системы и содержащие их фармацевтические композиции | |
| CN100502847C (zh) | 含有取代喹啉和取代二苯砜的组合物及其制药用途 | |
| RU2005125047A (ru) | Соединения карбоновых кислот | |
| JP2021503442A (ja) | 中枢および末梢神経系障害の治療のためのキナーゼ阻害剤 | |
| JP2002504134A (ja) | 疼痛を治療するためのドラフラジン類似体の使用 | |
| JP2005514380A5 (https=) |